Five useful features were included in the model (C10AX, C10AX without ezetimibe and PCSK9 inhibitor, PCSK9 inhibitors, maximum LDL-C level, and esophageal disorders [Clinical Classifications Software Refined category: DIG004]; Fig. 4). Here, PCSK9 is linked to esophageal disorder.